Lexicon Pharmaceuticals
LXRX
#7142
Rank
NZ$0.88 B
Marketcap
NZ$2.42
Share price
-1.41%
Change (1 day)
119.31%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.14 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.27 B25.42%
2023-12-31NZ$0.21 B77.33%
2022-12-31NZ$0.12 B256.12%
2021-12-31NZ$34.13 M-48.06%
2020-12-31NZ$65.71 M-85.28%
2019-12-31NZ$0.44 B-3.59%
2018-12-31NZ$0.46 B-10.72%
2017-12-31NZ$0.51 B12.87%
2016-12-31NZ$0.45 B-14.12%
2015-12-31NZ$0.53 B123.7%
2014-12-31NZ$0.23 B88.95%
2013-12-31NZ$0.12 B-0.94%
2012-12-31NZ$0.12 B-25%
2011-12-31NZ$0.17 B9.64%
2010-12-31NZ$0.15 B19.71%
2009-12-31NZ$0.12 B14.67%
2008-12-31NZ$0.11 B4.8%
2007-12-31NZ$0.10 B-27.38%
2006-12-31NZ$0.14 B-23.53%
2005-12-31NZ$0.19 B53.51%
2004-12-31NZ$0.12 B-30.21%
2003-12-31NZ$0.18 B198.05%
2002-12-31NZ$60.89 M16.97%
2001-12-31NZ$52.06 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
NZ$4.5 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$15.94 B 10,640.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ$2.03 B 1,269.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.69 B 1,716.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$89.78 B 60,372.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.41 B 850.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$6.57 B 4,325.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.91 B 513.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.93 B 529.11%๐Ÿ‡บ๐Ÿ‡ธ USA